Literature DB >> 24710373

Targeting a new regulator of erythropoiesis to alleviate anemia.

Robert F Paulson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24710373     DOI： 10.1038/nm.3524

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.

Authors:  Sara Gardenghi; Pedro Ramos; Maria Franca Marongiu; Luca Melchiori; Laura Breda; Ella Guy; Kristen Muirhead; Niva Rao; Cindy N Roy; Nancy C Andrews; Elizabeta Nemeth; Antonia Follenzi; Xiuli An; Narla Mohandas; Yelena Ginzburg; Eliezer A Rachmilewitz; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.

Authors:  Ilaria V Libani; Ella C Guy; Luca Melchiori; Raffaella Schiro; Pedro Ramos; Laura Breda; Thomas Scholzen; Amy Chadburn; YiFang Liu; Margrit Kernbach; Bettina Baron-Lühr; Matteo Porotto; Maria de Sousa; Eliezer A Rachmilewitz; John D Hood; M Domenica Cappellini; Patricia J Giardina; Robert W Grady; Johannes Gerdes; Stefano Rivella
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113

Review 3.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

Review 4.  Stress erythropoiesis: new signals and new stress progenitor cells.

Authors:  Robert F Paulson; Lei Shi; Dai-Chen Wu
Journal:  Curr Opin Hematol       Date:  2011-05       Impact factor: 3.284

Review 5.  What is really dangerous: anaemia or transfusion?

Authors:  A Shander; M Javidroozi; S Ozawa; G M T Hare
Journal:  Br J Anaesth       Date:  2011-12       Impact factor: 9.166

Review 6.  The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.

Authors:  Stefano Rivella
Journal:  Blood Rev       Date:  2012-04       Impact factor: 8.250

Review 7.  Erythropoietin in cancer patients: pros and cons.

Authors:  Mario Dicato; Laurent Plawny
Journal:  Curr Opin Oncol       Date:  2010-07       Impact factor: 3.645

8.  Iron Loading and Overloading due to Ineffective Erythropoiesis.

Authors:  Toshihiko Tanno; Jeffery L Miller
Journal:  Adv Hematol       Date:  2010-05-11

9.  Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women.

Authors:  Jon Ruckle; Mark Jacobs; William Kramer; Amelia E Pearsall; Ravindra Kumar; Kathryn W Underwood; Jasbir Seehra; Yijun Yang; Carolyn H Condon; Matthew L Sherman
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

10.  Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.

Authors:  Rajasekhar N V S Suragani; Samuel M Cadena; Sharon M Cawley; Dianne Sako; Dianne Mitchell; Robert Li; Monique V Davies; Mark J Alexander; Matthew Devine; Kenneth S Loveday; Kathryn W Underwood; Asya V Grinberg; John D Quisel; Rajesh Chopra; R Scott Pearsall; Jasbir Seehra; Ravindra Kumar
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440
View more
  11 in total

Review 1.  Beyond transfusion therapy: new therapies in thalassemia including drugs, alternate donor transplant, and gene therapy.

Authors:  John Porter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Muscarinic acetylcholine receptor regulates self-renewal of early erythroid progenitors.

Authors:  Gaurang Trivedi; Daichi Inoue; Cynthia Chen; Lillian Bitner; Young Rock Chung; Justin Taylor; Mithat Gönen; Jürgen Wess; Omar Abdel-Wahab; Lingbo Zhang
Journal:  Sci Transl Med       Date:  2019-09-25       Impact factor: 17.956

Review 3.  Anemia: progress in molecular mechanisms and therapies.

Authors:  Vijay G Sankaran; Mitchell J Weiss
Journal:  Nat Med       Date:  2015-03       Impact factor: 53.440

Review 4.  Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.

Authors:  Ryan G Walker; Tommaso Poggioli; Lida Katsimpardi; Sean M Buchanan; Juhyun Oh; Sam Wattrus; Bettina Heidecker; Yick W Fong; Lee L Rubin; Peter Ganz; Thomas B Thompson; Amy J Wagers; Richard T Lee
Journal:  Circ Res       Date:  2016-04-01       Impact factor: 17.367

5.  Questions and Answers About Myostatin, GDF11, and the Aging Heart.

Authors:  Elizabeth M McNally
Journal:  Circ Res       Date:  2016-01-08       Impact factor: 17.367

Review 6.  The role of TGFβ in hematopoiesis and myeloid disorders.

Authors:  Alex Bataller; Guillermo Montalban-Bravo; Kelly A Soltysiak; Guillermo Garcia-Manero
Journal:  Leukemia       Date:  2019-02-28       Impact factor: 11.528

7.  Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemia.

Authors:  Amaliris Guerra; Paraskevi Rea Oikonomidou; Sayantani Sinha; Jianbing Zhang; Vania Lo Presti; Callum R Hamilton; Laura Breda; Carla Casu; Ping La; Ana C Martins; Anoop K Sendamarai; Mark Fleming; Stefano Rivella
Journal:  Blood       Date:  2019-05-31       Impact factor: 25.476

Review 8.  Anemia in heart failure: still an unsolved enigma.

Authors:  Yash Paul Sharma; Navjyot Kaur; Ganesh Kasinadhuni; Akash Batta; Pulkit Chhabra; Samman Verma; Prashant Panda
Journal:  Egypt Heart J       Date:  2021-08-28

9.  Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.

Authors:  Reina Nagase; Daichi Inoue; Alessandro Pastore; Takeshi Fujino; Hsin-An Hou; Norimasa Yamasaki; Susumu Goyama; Makoto Saika; Akinori Kanai; Yasuyuki Sera; Sayuri Horikawa; Yasunori Ota; Shuhei Asada; Yasutaka Hayashi; Kimihito Cojin Kawabata; Reina Takeda; Hwei-Fang Tien; Hiroaki Honda; Omar Abdel-Wahab; Toshio Kitamura
Journal:  J Exp Med       Date:  2018-04-11       Impact factor: 14.307

Review 10.  Role of growth differentiation factor 11 in development, physiology and disease.

Authors:  Yonghui Zhang; Yong Wei; Dan Liu; Feng Liu; Xiaoshan Li; Lianhong Pan; Yi Pang; Dilong Chen
Journal:  Oncotarget       Date:  2017-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.